These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23979440)

  • 21. N-acetylcysteine for COPD: the evidence remains inconclusive.
    Turner RD; Bothamley GH
    Lancet Respir Med; 2014 Apr; 2(4):e3. PubMed ID: 24717631
    [No Abstract]   [Full Text] [Related]  

  • 22. Bioaccumulation and toxicodynamics of cadmium to freshwater planarian and the protective effect of N-acetylcysteine.
    Wu JP; Chen HC; Li MH
    Arch Environ Contam Toxicol; 2012 Aug; 63(2):220-9. PubMed ID: 22481525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute maternal oxidant exposure causes susceptibility of the fetal brain to inflammation and oxidative stress.
    Akhtar F; Rouse CA; Catano G; Montalvo M; Ullevig SL; Asmis R; Kharbanda K; Maffi SK
    J Neuroinflammation; 2017 Sep; 14(1):195. PubMed ID: 28962577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Viruses and oxidative stress].
    Weismann H
    Dtsch Med Wochenschr; 1996 May; 121(21):A8. PubMed ID: 8646971
    [No Abstract]   [Full Text] [Related]  

  • 25. N-acetylcysteine for COPD: the evidence remains inconclusive--authors' reply.
    Zheng JP; Zhong NS
    Lancet Respir Med; 2014 Apr; 2(4):e3-4. PubMed ID: 24717632
    [No Abstract]   [Full Text] [Related]  

  • 26. Copaiba Oil Decreases Oxidative Stress and Inflammation But not Colon Damage in Rats with TNBS-Induced Colitis.
    Barbosa MMC; Vicentini FA; Castro-Ghizoni CV; Lameira OA; Sa-Nakanishi AB; Bracht L; Peralta RM; Natali MRM; Bracht A; Comar JF
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):268-280. PubMed ID: 29446750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
    Yang C; Bosker FJ; Li J; Schoevers RA
    BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetylcysteine reduces oxidative stress in sickle cell patients.
    Nur E; Brandjes DP; Teerlink T; Otten HM; Oude Elferink RP; Muskiet F; Evers LM; ten Cate H; Biemond BJ; Duits AJ; Schnog JJ;
    Ann Hematol; 2012 Jul; 91(7):1097-105. PubMed ID: 22318468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylcysteine for chronic obstructive pulmonary disease?
    Lavietes MH
    Respiration; 1999; 66(6):491-2. PubMed ID: 10847827
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats.
    Ancha HR; Kurella RR; McKimmey CC; Lightfoot S; Harty RF
    Dig Dis Sci; 2009 Apr; 54(4):758-66. PubMed ID: 18716872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased oxidative stress in the airway and development of allergic inflammation in a mouse model of asthma.
    Park CS; Kim TB; Lee KY; Moon KA; Bae YJ; Jang MK; Cho YS; Moon HB
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):238-47. PubMed ID: 19788022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-acetylcysteine somewhere between Scylla and Charybdis.
    Sochman J
    J Am Coll Cardiol; 2010 Sep; 56(13):1067; author reply 1067-8. PubMed ID: 20846610
    [No Abstract]   [Full Text] [Related]  

  • 33. Is the oral acetylcysteine protocol the best treatment for late-presenting acetaminophen poisoning?
    Bond GR
    Ann Emerg Med; 2009 Oct; 54(4):615-7. PubMed ID: 19695740
    [No Abstract]   [Full Text] [Related]  

  • 34. IV versus oral N-acetylcysteine.
    Gupta AK; Su MK; Greller HA; Lee DC; Chan GM
    Ann Emerg Med; 2009 Dec; 54(6):857-8; author reply 858-9. PubMed ID: 19942075
    [No Abstract]   [Full Text] [Related]  

  • 35. An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis.
    Miner P; Wedel M; Bane B; Bradley J
    Aliment Pharmacol Ther; 2004 Feb; 19(3):281-6. PubMed ID: 14984374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects.
    Arstall MA; Yang J; Stafford I; Betts WH; Horowitz JD
    Circulation; 1995 Nov; 92(10):2855-62. PubMed ID: 7586252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted amelioration of cisplatin-induced ototoxicity in guinea pigs.
    Mohan S; Smyth BJ; Namin A; Phillips G; Gratton MA
    Otolaryngol Head Neck Surg; 2014 Nov; 151(5):836-9. PubMed ID: 25078416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Acetylcysteine for the prevention of renal dysfunction in high-risk patients undergoing coronary bypass graft surgery: an unfulfilled promise?
    Filep JG
    Crit Care Med; 2007 May; 35(5):1431-3. PubMed ID: 17446744
    [No Abstract]   [Full Text] [Related]  

  • 39. Beneficial effect of N-acetylcysteine against organophosphate toxicity in mice.
    Yurumez Y; Cemek M; Yavuz Y; Birdane YO; Buyukokuroglu ME
    Biol Pharm Bull; 2007 Mar; 30(3):490-4. PubMed ID: 17329844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology.
    Kontoghiorghes GJ; Kontoghiorghe CN
    Expert Opin Investig Drugs; 2019 Jul; 28(7):593-603. PubMed ID: 31185180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.